These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 29703243)

  • 1. Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing "One Health" community surveillance and emergency response practice.
    Tambo E; Adetunde OT; Olalubi OA
    Infect Dis Poverty; 2018 Apr; 7(1):37. PubMed ID: 29703243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).
    Ajayi NA; Nwigwe CG; Azuogu BN; Onyire BN; Nwonwu EU; Ogbonnaya LU; Onwe FI; Ekaete T; Günther S; Ukwaja KN
    Int J Infect Dis; 2013 Nov; 17(11):e1011-6. PubMed ID: 23871405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research as a pillar of Lassa fever emergency response: lessons from Nigeria.
    Olayinka AT; Nwafor CD; Akano A; Jan K; Ebhodaghe B; Elimian K; Ochu C; Okwor T; Ipadeola O; Ukponu W; Okudo I; Peter C; Ilori E; Ihekweazu C
    Pan Afr Med J; 2020; 37():179. PubMed ID: 33447334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in Lassa Fever Cases in Nigeria, January-March 2018.
    Ilori EA; Frank C; Dan-Nwafor CC; Ipadeola O; Krings A; Ukponu W; Womi-Eteng OE; Adeyemo A; Mutbam SK; Musa EO; Lasuba CLP; Alemu W; Okogbenin S; Ogbaini E; Unigwe U; Ogah E; Onoh R; Abejegah C; Ayodeji O; Ihekweazu C
    Emerg Infect Dis; 2019 May; 25(5):1026-1027. PubMed ID: 30807268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019.
    Dan-Nwafor CC; Furuse Y; Ilori EA; Ipadeola O; Akabike KO; Ahumibe A; Ukponu W; Bakare L; Okwor TJ; Joseph G; Mba NG; Akano A; Olayinka AT; Okoli I; Okea RA; Makava F; Ugbogulu N; Oladele S; Namara G; Muwanguzi EN; Naidoo D; Mutbam SK; Okudo I; Woldetsadik SF; Lasuba CL; Ihekweazu C
    Euro Surveill; 2019 May; 24(20):. PubMed ID: 31115314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive epidemiology of Lassa fever in Nigeria, 2012-2017.
    Okoro OA; Bamgboye E; Dan-Nwafor C; Umeokonkwo C; Ilori E; Yashe R; Balogun M; Nguku P; Ihekweazu C
    Pan Afr Med J; 2020; 37():15. PubMed ID: 33062117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Cross-Border Preparedness and Response: Lessons Learned from 3 Lassa Fever Outbreaks Across Benin, Nigeria, and Togo, 2017-2019.
    Kakaī CG; Okunromade OF; Dan-Nwafor CC; Chabi AIB; Martial GTP; Dalhat MM; Ward S; Tante O; Nguku PM; Hamadi A; Ilori E; Lokossou V; Brito C; Ojo OE; Kone I; Agbeko TT; Ihekweazu C; Merrill RD
    Health Secur; 2020 Jan; 18(S1):S105-S112. PubMed ID: 32004125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
    Ilori EA; Furuse Y; Ipadeola OB; Dan-Nwafor CC; Abubakar A; Womi-Eteng OE; Ogbaini-Emovon E; Okogbenin S; Unigwe U; Ogah E; Ayodeji O; Abejegah C; Liasu AA; Musa EO; Woldetsadik SF; Lasuba CLP; Alemu W; Ihekweazu C;
    Emerg Infect Dis; 2019 Jun; 25(6):1066-1074. PubMed ID: 31107222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lassa fever amidst the COVID-19 pandemic in Africa: A rising concern, efforts, challenges, and future recommendations.
    Uwishema O; Alshareif BAA; Yousif MYE; Omer MEA; Sablay ALR; Tariq R; Zahabioun A; Mwazighe RM; Onyeaka H
    J Med Virol; 2021 Dec; 93(12):6433-6436. PubMed ID: 34289134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
    Dalhat MM; Olayinka A; Meremikwu MM; Dan-Nwafor C; Iniobong A; Ntoimo LF; Onoh I; Mba S; Ohonsi C; Arinze C; Esu EB; Nwafor O; Oladipupo I; Onoja M; Ilori E; Okonofua F; Ochu CL; Igumbor EU; Adetifa I
    PLoS One; 2022; 17(12):e0279467. PubMed ID: 36584167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Lassa Fever: Systemic and structural barriers to disease detection and response in Sierra Leone.
    Rohan H
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010423. PubMed ID: 35587495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges.
    Shaffer JG; Schieffelin JS; Gbakie M; Alhasan F; Roberts NB; Goba A; Randazzo J; Momoh M; Moon TD; Kanneh L; Levy DC; Podgorski RM; Hartnett JN; Boisen ML; Branco LM; Samuels R; Grant DS; Garry RF;
    PLoS One; 2019; 14(3):e0214284. PubMed ID: 30921383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice.
    Fisher-Hoch SP; Tomori O; Nasidi A; Perez-Oronoz GI; Fakile Y; Hutwagner L; McCormick JB
    BMJ; 1995 Sep; 311(7009):857-9. PubMed ID: 7580496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria.
    Happi AN; Olumade TJ; Ogunsanya OA; Sijuwola AE; Ogunleye SC; Oguzie JU; Nwofoke C; Ugwu CA; Okoro SJ; Otuh PI; Ngele LN; Ojo OO; Adelabu A; Adeleye RF; Oyejide NE; Njaka CS; Heeney JL; Happi CT
    Microbiol Spectr; 2022 Aug; 10(4):e0036622. PubMed ID: 35913205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Lassa Fever and Factors Associated with Deaths, Bauchi State, Nigeria, 2015-2018.
    Abdulkarim MA; Babale SM; Umeokonkwo CD; Bamgboye EA; Bashorun AT; Usman AA; Balogun MS
    Emerg Infect Dis; 2020 Apr; 26(4):799-801. PubMed ID: 32186504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality Among Confirmed Lassa Fever Cases During the 2015-2016 Outbreak in Nigeria.
    Buba MI; Dalhat MM; Nguku PM; Waziri N; Mohammad JO; Bomoi IM; Onyiah AP; Onwujei J; Balogun MS; Bashorun AT; Nsubuga P; Nasidi A
    Am J Public Health; 2018 Feb; 108(2):262-264. PubMed ID: 29267063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Lassa virus among rodents trapped in three South-South States of Nigeria.
    Agbonlahor DE; Erah A; Agba IM; Oviasogie FE; Ehiaghe AF; Wankasi M; Eremwanarue OA; Ehiaghe IJ; Ogbu EC; Iyen RI; Abbey S; Tatfeng MY; Uhunmwangho J
    J Vector Borne Dis; 2017; 54(2):146-150. PubMed ID: 28748835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the COVID-19 pandemic masking the deadlier Lassa fever epidemic in Nigeria?
    Reuben RC; Danladi MMA; Pennap GR
    J Clin Virol; 2020 Jul; 128():104434. PubMed ID: 32434707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the zoonotic niche of Lassa fever in Africa.
    Mylne AQ; Pigott DM; Longbottom J; Shearer F; Duda KA; Messina JP; Weiss DJ; Moyes CL; Golding N; Hay SI
    Trans R Soc Trop Med Hyg; 2015 Aug; 109(8):483-92. PubMed ID: 26085474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A challenging response to a Lassa fever outbreak in a non endemic area of Sierra Leone in 2019 with export of cases to The Netherlands.
    Njuguna C; Vandi M; Liyosi E; Githuku J; Wurie A; Njeru I; Raftery P; Amuzu C; Maruta A; Musoke R; Fahnbulleh M; Bunting J; Gbandeh S; Talisuna A; Yoti Z
    Int J Infect Dis; 2022 Apr; 117():295-301. PubMed ID: 35167968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.